Author: Andrew Kollath

Evaluation of Brain Nuclear Medicine Imaging Tracers in a Murine Model of Sepsis-Associated Encephalopathy. – Molecular Imaging and Biology 2018 May.

Thallium Labeled Citrate-Coated Prussian Blue Nanoparticles as Potential Imaging Agent. – Contrast Media and Molecular Imaging 2018 April.

Age-dependent changes at the blood-brain barrier. A Comparative structural and functional  study in young adult and middle aged rats. – Brain Res Bull. 2018 Mar 6.

Functional shift with maintained regenerative potential following portal vein ligation. – Scientific Reports 2017 Dec 22.

Direct immobilization of manganese chelates on silica nanospheres for MRI applications – J Colloid Interface Sci. 2017 Mar 14.

Comparative erythrocyte deformability investigations by filtrometry, slit-flow and rotational ektacytometry in a long-term follow-up animal study on splenectomy and different spleen preserving operative techniques: Partial or subtotal spleen resection and spleen autotransplantation – Clin Hemorheol Microcirc 2017 Jan 27.

State of the art in vivo imaging techniques for laboratory animals – Laboratory Animals 2017 Jan.

Biodistribution Investigations of Technetium-Labelled Murine Bone Marrow-Derived Extracellular Vesicles by Nanospect/Ct – Central European Journal of Occupational and Environmental Medicine 2016 Nov.

Influence of barium sulfate X-ray imaging contrast material on properties of floating drug delivery tablets – Eur J Pharm Sci. 2016 Sep 28.

Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress – Am J Physiol Heart Circ Physiol. 2016 Aug 12.

Radiolabeling of Extracellular Vesicles with 99mTc for Quantitative In Vivo Imaging Studies – Cancer Biother Radiopharm. 2016 Jun

Production and in vivo imaging of (203)Pb as a surrogate isotope for in vivo (212)Pb internal absorbed dose studies – Appl Radiat Isot. 2016 Apr 22.

Radiomics-based differentiation of lung disease models generated by polluted air based on X-ray computed tomography data – BMC Med Imaging. 2016 Feb 11.

Synthesis, Characterization and Application of Core-Shell Co0.16Fe2.84O4@NaYF4(Yb, Er) and Fe3O4@NaYF4(Yb, Tm) Nanoparticle as Tri-modal (MRI, PET/SPECT and Optical) Imaging Agents – Bioconjug. Chem. 2015 Aug 14.

Preformulation studies and optimization of sodium alginate based floating drug delivery system for eradication of Helicobacter pylori – Eur J Pharm Biopharm 2015 Aug 3.

A novel SPECT-based approach reveals early mechanisms of central and peripheral inflammation after cerebral ischemia – J. Cereb Blood Flow Metab. 2015 July 29.

Al(OH)3 decilitered synthesis of water-soluble, magnetic, radiolabelled and fluorescent hydroxyapatite nanoparticles – Chem. Commun. 2015 Jun 7.

Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model – Arthritis Reumathol 2014 Oct.

The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment – J. Exp Med. 2014. Sept 15.

Longitudinal in vivo MR imaging of live earthworms – Journal of Experimental Zoology Part A: Ecological Genetics and Physiology 2014 Jul 25.

Motion based X-ray imaging modality – Medical Imaging, IEEE Transactions 2014 Jun 10.

Aluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI andPET imaging – Biomaterials 2014 Apr 24.

Quantitative liver lesion volume determination by nanoparticle-based SPECT – Mol Imaging Biol. 2014 Apr

Demonstration of Metabolic and Cellular Effects of Portal Vein Ligation Using Multi-Modal PET/MRI Measurements in Healthy Rat Liver – PLoS One 2014 Mar 5.

The role of molecular imaging in modern drug development – Drug Discovery Today 2014 Jan 13.

Preclinical Imaging: an Essential Ally in Modern Biosciences – Molecular Diagnosis & Therapy 2013 Oct 22.

(99m)Tc-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities – Journal of Pharmaceutics 2013 Apr 2.

Osteogenic potential of Sr-doped calcium phosphate hollow spheres in vitro and in vivo – J. Biomed Mater Res A 2013 Jan 28.

In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse – Brain Research Bulletin 2013 Jan 11.

Systematic evaluation of 99mTc-tetrofosmin versus 99mTc-sestamibi to study murine myocardial perfusion in small animal SPECT/CT – EJNMMI Research 2012 May 24.

Noninvasive molecular imaging of neuroinflammation –  Journal of Cerebral Blood Flow & Metabolism 2012 May 2.

The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson’s disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015 – Brain Research Bulletin  2012 Mar 7.

Compromised bone healing following spacer removal in a rat femoral defect model – Acta Physiologica Hungarica 2012 Feb 16.

[¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer’s disease – Neurochemistry International 2011 Dec 28.

In vivo evaluation of an injectable premixed radiopaque calcium phosphate cement – International Journal of Biomaterials 2011 – Int J Biomater. 2011; 2011:232574. Epub 2011 May 31.

CROmed takes part and has oral and poster presentations at the PSMR 2018 Conference in Italy, 21-23 May 2018.

As environmental isotopic imaging measurements are important to us, CROmed proudly sponsors the TREICEP Conference in Veszprém, 22-25 May 2018.

CROmed takes part in EANM 2016 in Barcelona, 15-19 October 2016.

CROmed is delivering a Continuing Medical Education presentation on Multimodal Imaging in Drug Development during the European Association of Nuclear Medicine’s Current Congress in Hamburg, 10-14 October 2015.

CROmed takes part in ICCU 2015 Meeting in Lisboa, 10-12 April 2015.

CROmed takes part and has poster presentations on 10th European Molecular Imaging Meeting 18-20 March 2015, Tubingen, Germany.

  1. Detection of microscopic metastatic liver disease in a mouse model using inhomogeneity parameters in particle-based liver SPECT imaging
  2. Early effects of systemic inflammation on brain injury and peripheral organs after cerebral ischemia

CROmed takes part in InMind Meeting in Bonn, 26-27 February 2015.

CROmed takes part in WMIC 2014, Seoul, Korea 17-20 September 2014.

CROmed has poster presentation in the Congress of World Federation of Nuclear Medicine and Biology, Cancun, Mexico, 27-31 August, 2014.

Preclinical SPECT liver study of tumour caused inhomogenous activity distribution characterised by simple parameters

CROmed has three poster presentations in Joint Meeting of the Federation of European Physiological Society and the Hungarian Physiological Society Budapest Hungary 27-30 August 2014:

  1. The effects of body mass on MRgluc-related metabolic activity in mouse joints investigated by in vivo dynamic PET/MRI
  2. In vivo imaging of brain after cerebral ischaemia using SPECT/CT in mice
  3. How to use PET/MRI to observe metabolic and cellular effects of portal vein ligation in healthy rat liver

CROmed takes part in BIO-Convention as Hungarian Exhibitor. Please do not forget meet us in San Diego, CA, USA 23-26 June, 2014. You can also rend us meeting request.

CROmed has two poster presentations in 9th European Molecular Imaging Meeting, 4-6 June, 2014, Antwerpen, Belgium:

  1. Production and SPECT/CT in-vivo mouse biodistribution of 203Pb-chloride as surrogate dosimetric isotope in 212Pb/212Bi alpha-therapy
  2. Synthesis and in-vivo use of tri-modality core-shell nanoparticles with PET, MRI and fluorescence signals

CROmed has poster presentation in 82nd European Atherosclerosis Society Congress, 31 May-3 June, Madrid, Spain: Role of In Vivo Imaging of Cardiovascular Research, Diagnosis and Treatment.

CROmed is proudly sponsoring Neuroreceptor Mapping 2014, Amsterdam Neuroscience and PET/SPECT/MR synergistic-please come to Amsterdam and see for yourself. Amsterdam, The Netherlands 21-24 May, 2014.

CROmed participates in XIII Turku PET Symposium with an oral presentation and several posters, Finland 24 – 27 May, 2014.

We are among the first groups in multimodal PET/MRI contrast agent applications. We know bimodal tracers provide greatly increased biologic sensitivity and one-step internally validated results.

So we are proud to support PSMR 2014, the leading world event in the field of PET/MRI applications of multimodal contrast agents. Kos, Greece, 19-21 May, 2014.
On PSMR 2014 CROmed has two oral presentations:

  1. Proof-of-principle study with 68 Ga/ Gd labelled PET/MRI imaging probe for pH assessment.
  2. Simple radiolabelling of inorganic core-shell nanoparticles for multimodality imaging.

CROmed participates on Odense Spring Meeting with an oral presentation about a new radiolabeled antibiotic to image tuberculosis. Odense, Denmark 12-14 May 2014

CROmed presents poster in Stem Cell Summit 2014 Cambridge, USA, 23-25 April 2014

CROmed takes part in the International Conference on Radiopharmacy and Radiopharmaceutils in March: Madrid, 27-28 March 2014.

CROmed takes part in NuklearMedizin Congress in Hannover, Germany 26-29 March 2014

CROmed takes part in BioSpring Europe, Torino, Italy, 10-12 March, 2014

CROmed has a poster presentation on 6th International Conference on Drug Discovery and Therapy, Dubai, 10-12 February 2014 Poster # 63

Advances and Applications for Positron Emission Tomography-Magnetic Resonance Hybrid Imaging
http://www.icddt.com
Meet us in Dubai and get more about our exciting results.

CROmed has a poster on IBRO Workshop 2014, Debrecen, Hungary 16-17 January 2014
Quantitative In Vivo Imaging in Brain Research http://ibro2014.unideb.hu/en/pages/Abstracts

CROmed has an oral presentation on the Congress of the Hungarian Experimental and Clinical Pharmacologist Association 2013 event, Debrecen, Hungary 12-14 December 2013.

CROmed continues obtaining Quality Nano Transnational Access grants
for 2014 with the Joint Research Centre in the field of radiolabeled industrial nanoparticle studies.

CROmed takes part at Bio Europe Vienna (November 4-6)
Find us at the Hungarian booth, and let’s make a conversation about your ideas.

CROmed has a presentation on the Symposium on the First Preclinical Nuclear Imaging on 4th November
In vivo kinetic brain mapping of 18F-FDDNP non-specific binding for transgenic mouse models of Alzheimer’s Disease.

CROmed takes part at the Protein Discovery Summit in San Diego
Find us and tell your ideas in San Diego from 23-25 October 2013.

Meet with CROmed at the EANM’13 Annual Congress (October 19 – 23, 2013 in Lyon/FRANCE)
EANM’13 – Annual Congress of the European Association of Nuclear Medicine
We have posters and oral presentation:
Poster:
PET/MRI/SPECT/CT in vivo longitudinal imaging of Earthworm (Lumbricus terrestris L.),
as a novel aspect for toxicological testing Poster #P494
The Role of Acetyl-L-Carnitine in the Mice Brain Glucose Uptake Poster #PW050
Oral presentations:
Cyclotron activated nanoparticles: application in PET/SPECT imaging
Metabolic PET/CT investigations on shellfish: biomarker feasibility of important environmental sentinel organisms

Let’s meet with us at Drug Discovery Week Europe: (October 9-10, Berlin)

CROmed has a poster presentation in Savannah at the WMIC 2013
World Molecular Imaging Congress 2013 in (September 18-21 – Savannah, Georgia)
Oral Presentation:
In vivo basic tracer pharmacokinetic analysis for transgenic mouse
models of Alzheimer’s disease: #1700327

CROmed attended at Neurodegenerative Conditions Research and Development Conference – September 9-10, Boston

BioForum 2013
Meet us in our hometown. Budapest hosts the BioForum, the leading Central European bio event and CROmed has a booth there.

EMIM 2013
CROmed will present one oral paper and two posters at the European Molecular Imaging Meeting in Torino, 26-28 May 2013. An invited talk about multi-modal probes in the Focus series is also foreseen at EMIM by us.

SNMMI 2013
CROmed will be there in Vancouver for the Society of Nuclear Medicine and Molecular Imaging annual congress 8-11 June 2013. To schedule a meeting please contact us

Meet CROmed in Chicago
at BIO International Convention 22-25 April 2013. Please visit us at the booth #0610 and share your ideas with us

Meet us in Barcelona
on the event Bio-Spring Europe 11-13 March 2013

Successful R&I in Europe
CROmed has a presentation on the event Successful R&I in Europe, in Düsseldorf 7-8 March 2013.

Meet us at EANM 2012, Milan
CROmed makes three oral presentations and two posters at the European Association of Nuclear Medicine 2012 Annual Conference in Milan, Italy.
Presentation #OP364 presents a novel model for radiopharmaceutical investigators and #OP523 deals with quantitative SPECT by monitoring liver lesions in mouse.
Presentation #OP670 presents a small animal PET/MR System.
Poster #P0089 deals with evaluation of 177Lu-nimotuzumab for targeted radioimmunotherapy of EGFR expressing tumors, and poster # PW030 presents a PET/MRI study by [11C]raclopride in rat.

WMIC, WMIS
CROmed is mentioned on the title page on the homepage of WMIC and also on the homepage of WMIS connected with SPECT/MRI

WMIC 2012, Dublin
CROmed presented five posters at the World Molecular Imaging Conference 2012 in Dublin, Ireland.

Meet us at SNM
CROmed will be attending the 2012 SNM congress in Miami. To schedule a meeting between 10 and 13 June, please contact us at office[at]cromedresearch[dot]com.

European Symposium of Radiochemistry and Radiopharmacy 2012 Nantes
CROmed will deliver an Expert Panel talk on small animal images in drug development at the ESRR 2012 conference in Nantes, France in the Saturday, 28 April Drug Development Panel

CROmed has won a Joint Research Centre Transnational Access grant to continue scientific work in the field of radiolabeled nanoparticles

Imaging in Drug Discovery & Development, WPC2011, Philadelphia
CROmed exhibited a poster about our company at the World Pharma Congress

JSNM 2011, Tsukuba
CROmed has presented the use of PET/MRI imaging technology in rodents in two oral presentations at the 51st Conference of Japanese Nuclear Medicine Society in Tsukuba, Japan, 27-29 October 2011.

EANM 2011, Birmingham
CROmed makes two oral presentations at the European Association of Nuclear Medicine 2011 Annual Conference in Birmingham, UK.
Presentation #OP268 presents our proprietary SPECT/PET-MRI nanoparticle contrast agent technology and #OP273 deals with Cannabinoid-1 receptor imaging in the CNS offered by us.

WMIC 2011, San Diego
CROmed presents three posters at the World Molecular Imaging Conference 2011 in San Diego, CA, USA

World Pharma Congress 2011
The Zooming In Concept poster